BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 38252293)

  • 21. Factors influencing postoperative morbidity, mortality, and survival after resection for hilar cholangiocarcinoma.
    Su CH; Tsay SH; Wu CC; Shyr YM; King KL; Lee CH; Lui WY; Liu TJ; P'eng FK
    Ann Surg; 1996 Apr; 223(4):384-94. PubMed ID: 8633917
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oncological benefit of preoperative endoscopic biliary drainage in patients with hilar cholangiocarcinoma.
    Hirano S; Tanaka E; Tsuchikawa T; Matsumoto J; Kawakami H; Nakamura T; Kurashima Y; Ebihara Y; Shichinohe T
    J Hepatobiliary Pancreat Sci; 2014 Aug; 21(8):533-40. PubMed ID: 24464984
    [TBL] [Abstract][Full Text] [Related]  

  • 23. R0 but not R1/R2 resection is associated with better survival than palliative photodynamic therapy in biliary tract cancer.
    Matull WR; Dhar DK; Ayaru L; Sandanayake NS; Chapman MH; Dias A; Bridgewater J; Webster GJ; Bong JJ; Davidson BR; Pereira SP
    Liver Int; 2011 Jan; 31(1):99-107. PubMed ID: 20846273
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pathological confirmation of para-aortic lymph node status as a potential criterion for the selection of intrahepatic cholangiocarcinoma patients for radical resection with regional lymph node dissection.
    Nakayama T; Tsuchikawa T; Shichinohe T; Nakamura T; Ebihara Y; Hirano S
    World J Surg; 2014 Jul; 38(7):1763-8. PubMed ID: 24378552
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Natural history of metastatic biliary tract cancer (BTC) patients with good performance status (PS) who were treated with only best supportive care (BSC).
    Ji JH; Song HN; Kim RB; Oh SY; Lim HY; Park JO; Park SH; Kim MJ; Lee SI; Ryou SH; Hwang IG; Jang JS; Kim HJ; Choi JY; Kang JH
    Jpn J Clin Oncol; 2015 Mar; 45(3):256-60. PubMed ID: 25628352
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The morbidity, mortality, and prognostic factors for ampullary carcinoma and distal cholangiocarcinoma.
    Shimizu Y; Kimura F; Shimizu H; Yoshidome H; Ohtsuka M; Miyazaki M
    Hepatogastroenterology; 2008; 55(82-83):699-703. PubMed ID: 18613437
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Positive peritoneal washing cytology in multiple cavities can predict poor prognosis of advanced gastric cancer patients.
    Homma Y; Ushida S; Yamada M; Kobayashi H; Suzuki K
    Ann Surg Oncol; 2010 Feb; 17(2):455-60. PubMed ID: 19847567
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic impact of lung recurrence in patients with biliary tract cancer.
    Sumiyoshi T; Uemura K; Shintakuya R; Okada K; Serikawa M; Ishii Y; Arihiro K; Murakami Y; Murashita J; Takahashi S
    Langenbecks Arch Surg; 2023 Jul; 408(1):290. PubMed ID: 37522989
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognosis after resection for hepatitis B virus-associated intrahepatic cholangiocarcinoma.
    Wu ZF; Wu XY; Zhu N; Xu Z; Li WS; Zhang HB; Yang N; Yao XQ; Liu FK; Yang GS
    World J Gastroenterol; 2015 Jan; 21(3):935-43. PubMed ID: 25624728
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment and Prognosis for Patients With Intrahepatic Cholangiocarcinoma: Systematic Review and Meta-analysis.
    Mavros MN; Economopoulos KP; Alexiou VG; Pawlik TM
    JAMA Surg; 2014 Jun; 149(6):565-74. PubMed ID: 24718873
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The expression of matrix metalloproteinases in intrahepatic cholangiocarcinoma, hilar (Klatskin tumor), middle and distal extrahepatic cholangiocarcinoma, gallbladder cancer, and ampullary carcinoma: role of matrix metalloproteinases in tumor progression and prognosis.
    Kirimlioğlu H; Türkmen I; Başsüllü N; Dirican A; Karadağ N; Kirimlioğlu V
    Turk J Gastroenterol; 2009 Mar; 20(1):41-7. PubMed ID: 19330734
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic factors of intrahepatic cholangiocarcinoma after hepatic resection: univariate and multivariate analysis.
    Hanazaki K; Kajikawa S; Shimozawa N; Shimada K; Hiraguri M; Koide N; Adachi W; Amano J
    Hepatogastroenterology; 2002; 49(44):311-6. PubMed ID: 11995440
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Surgery for Recurrent Biliary Tract Cancer: A Single-center Experience With 74 Consecutive Resections.
    Takahashi Y; Ebata T; Yokoyama Y; Igami T; Sugawara G; Mizuno T; Nimura Y; Nagino M
    Ann Surg; 2015 Jul; 262(1):121-9. PubMed ID: 25405563
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic value of lymphadenectomy for long-term outcomes in node-negative intrahepatic cholangiocarcinoma: A multicenter study.
    Yoh T; Cauchy F; Le Roy B; Seo S; Taura K; Hobeika C; Dokmak S; Farges O; Gelli M; Sa Cunha A; Adam R; Uemoto S; Soubrane O
    Surgery; 2019 Dec; 166(6):975-982. PubMed ID: 31421869
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Locoregional recurrence after curative intent resection for intrahepatic cholangiocarcinoma: implications for adjuvant radiotherapy.
    Song S; Kim K; Chie EK; Kim S; Park HJ; Yi NJ; Suh KS; Ha SW
    Clin Transl Oncol; 2015 Oct; 17(10):825-9. PubMed ID: 26041722
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differences in Prognostic Factors and Recurrence Patterns After Curative-Intent Resection of Perihilar and Distal Cholangiocarcinomas.
    Sallinen V; Sirén J; Mäkisalo H; Lehtimäki TE; Lantto E; Kokkola A; Nordin A
    Scand J Surg; 2020 Sep; 109(3):219-227. PubMed ID: 30791825
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Resection of hilar cholangiocarcinoma.
    Strasberg SM
    HPB Surg; 1998; 10(6):415-8. PubMed ID: 9515244
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Surgery for hilar cholangiocarcinoma; a 10 year experience of a tertiary referral centre in the UK.
    Silva MA; Tekin K; Aytekin F; Bramhall SR; Buckels JA; Mirza DF
    Eur J Surg Oncol; 2005 Jun; 31(5):533-9. PubMed ID: 15922889
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A phase II study of uracil-tegafur plus doxorubicin and prognostic factors in patients with unresectable biliary tract cancer.
    Furuse J; Okusaka T; Ohkawa S; Nagase M; Funakoshi A; Boku N; Yamao K; Yamaguchi T; Sato T
    Cancer Chemother Pharmacol; 2009 Dec; 65(1):113-20. PubMed ID: 19404641
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Liver transplantation for irresectable hilar cholangiocarcinoma].
    Lai Y; Dong J; Duan W; Yu Q; Meng X; Ye S; Zhang D; Huang Z
    Zhonghua Wai Ke Za Zhi; 2014 Nov; 52(11):839-44. PubMed ID: 25604023
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.